Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma

Irwin Leav, Cristina Magi Galluzzi, Jeffrey Ziar, Philip Stork, Shuk Mei Ho, Massimo Loda

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Our recent studies have implicated the TGF-α/epidermal growth factor receptor pathway in the genesis of testosterone (T) and estradiol-17β (E 2)- Induced dysplasia in the dorsolateral prostate (DLP) of Noble rats. This pathway was also found to be markedly up-regulated in the androgen- independent transplantable carcinoma that arose from the DLP of a Noble rat. In the current study, we investigated the expression of mitogen-activated protein kinase (MAP-kinase) and mitogen-activated kinase phosphatase-1 (MKP- 1), key downstream regulators of growth factor-activated signal transduction in the DLP of castrated, castrated T-supplemented, and T + E 2-treated rats and in the androgen-independent transplantable carcinoma. Both MAP-kinase and MKP-1 expression in the DLP were found to be dependent on androgen stimulation. Immunoblots of DLP from T + E 2-treated rats demonstrated a selective decline in MKP-1 levels with no alteration in MAP-kinase expression. These findings suggest that the dual hormone treatment induces changes in the signal transduction pathway, which favors the protracted mitogenic action of MAP-kinase. In situ hybridization and immunohistochemistry findings corroborated the immunoblot data but also revealed that both MAP-kinase and MKP-1 were strongly expressed in severely dysplastic lesions, which may indicate the presence of transformed cells in these foci. In this regard, both proteins were strongly expressed in samples of the androgen-independent transplantable carcinoma. Taken together, results from this and our recent study suggest that alterations in a growth factor- MAP-kinase pathway may be important events in the initiation and progression of prostatic carcinoma.

Original languageEnglish (US)
Pages (from-to)361-370
Number of pages10
JournalLaboratory Investigation
Volume75
Issue number3
StatePublished - Sep 1996

Fingerprint

Gonadal Steroid Hormones
Mitogen-Activated Protein Kinases
Mitogens
Prostate
Carcinoma
Androgens
Signal Transduction
Intercellular Signaling Peptides and Proteins
Epidermal Growth Factor Receptor
In Situ Hybridization
Testosterone
phosphatase-1 kinase
Estradiol
Immunohistochemistry
Hormones
Proteins

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. / Leav, Irwin; Galluzzi, Cristina Magi; Ziar, Jeffrey; Stork, Philip; Ho, Shuk Mei; Loda, Massimo.

In: Laboratory Investigation, Vol. 75, No. 3, 09.1996, p. 361-370.

Research output: Contribution to journalArticle

@article{509be1c858fb483ab7e6dcbe2915d33c,
title = "Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma",
abstract = "Our recent studies have implicated the TGF-α/epidermal growth factor receptor pathway in the genesis of testosterone (T) and estradiol-17β (E 2)- Induced dysplasia in the dorsolateral prostate (DLP) of Noble rats. This pathway was also found to be markedly up-regulated in the androgen- independent transplantable carcinoma that arose from the DLP of a Noble rat. In the current study, we investigated the expression of mitogen-activated protein kinase (MAP-kinase) and mitogen-activated kinase phosphatase-1 (MKP- 1), key downstream regulators of growth factor-activated signal transduction in the DLP of castrated, castrated T-supplemented, and T + E 2-treated rats and in the androgen-independent transplantable carcinoma. Both MAP-kinase and MKP-1 expression in the DLP were found to be dependent on androgen stimulation. Immunoblots of DLP from T + E 2-treated rats demonstrated a selective decline in MKP-1 levels with no alteration in MAP-kinase expression. These findings suggest that the dual hormone treatment induces changes in the signal transduction pathway, which favors the protracted mitogenic action of MAP-kinase. In situ hybridization and immunohistochemistry findings corroborated the immunoblot data but also revealed that both MAP-kinase and MKP-1 were strongly expressed in severely dysplastic lesions, which may indicate the presence of transformed cells in these foci. In this regard, both proteins were strongly expressed in samples of the androgen-independent transplantable carcinoma. Taken together, results from this and our recent study suggest that alterations in a growth factor- MAP-kinase pathway may be important events in the initiation and progression of prostatic carcinoma.",
author = "Irwin Leav and Galluzzi, {Cristina Magi} and Jeffrey Ziar and Philip Stork and Ho, {Shuk Mei} and Massimo Loda",
year = "1996",
month = "9",
language = "English (US)",
volume = "75",
pages = "361--370",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the noble rat model of sex hormone-induced prostatic dysplasia and carcinoma

AU - Leav, Irwin

AU - Galluzzi, Cristina Magi

AU - Ziar, Jeffrey

AU - Stork, Philip

AU - Ho, Shuk Mei

AU - Loda, Massimo

PY - 1996/9

Y1 - 1996/9

N2 - Our recent studies have implicated the TGF-α/epidermal growth factor receptor pathway in the genesis of testosterone (T) and estradiol-17β (E 2)- Induced dysplasia in the dorsolateral prostate (DLP) of Noble rats. This pathway was also found to be markedly up-regulated in the androgen- independent transplantable carcinoma that arose from the DLP of a Noble rat. In the current study, we investigated the expression of mitogen-activated protein kinase (MAP-kinase) and mitogen-activated kinase phosphatase-1 (MKP- 1), key downstream regulators of growth factor-activated signal transduction in the DLP of castrated, castrated T-supplemented, and T + E 2-treated rats and in the androgen-independent transplantable carcinoma. Both MAP-kinase and MKP-1 expression in the DLP were found to be dependent on androgen stimulation. Immunoblots of DLP from T + E 2-treated rats demonstrated a selective decline in MKP-1 levels with no alteration in MAP-kinase expression. These findings suggest that the dual hormone treatment induces changes in the signal transduction pathway, which favors the protracted mitogenic action of MAP-kinase. In situ hybridization and immunohistochemistry findings corroborated the immunoblot data but also revealed that both MAP-kinase and MKP-1 were strongly expressed in severely dysplastic lesions, which may indicate the presence of transformed cells in these foci. In this regard, both proteins were strongly expressed in samples of the androgen-independent transplantable carcinoma. Taken together, results from this and our recent study suggest that alterations in a growth factor- MAP-kinase pathway may be important events in the initiation and progression of prostatic carcinoma.

AB - Our recent studies have implicated the TGF-α/epidermal growth factor receptor pathway in the genesis of testosterone (T) and estradiol-17β (E 2)- Induced dysplasia in the dorsolateral prostate (DLP) of Noble rats. This pathway was also found to be markedly up-regulated in the androgen- independent transplantable carcinoma that arose from the DLP of a Noble rat. In the current study, we investigated the expression of mitogen-activated protein kinase (MAP-kinase) and mitogen-activated kinase phosphatase-1 (MKP- 1), key downstream regulators of growth factor-activated signal transduction in the DLP of castrated, castrated T-supplemented, and T + E 2-treated rats and in the androgen-independent transplantable carcinoma. Both MAP-kinase and MKP-1 expression in the DLP were found to be dependent on androgen stimulation. Immunoblots of DLP from T + E 2-treated rats demonstrated a selective decline in MKP-1 levels with no alteration in MAP-kinase expression. These findings suggest that the dual hormone treatment induces changes in the signal transduction pathway, which favors the protracted mitogenic action of MAP-kinase. In situ hybridization and immunohistochemistry findings corroborated the immunoblot data but also revealed that both MAP-kinase and MKP-1 were strongly expressed in severely dysplastic lesions, which may indicate the presence of transformed cells in these foci. In this regard, both proteins were strongly expressed in samples of the androgen-independent transplantable carcinoma. Taken together, results from this and our recent study suggest that alterations in a growth factor- MAP-kinase pathway may be important events in the initiation and progression of prostatic carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0029840655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029840655&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 361

EP - 370

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 3

ER -